| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |